DOXYLAMINE SUCCINATE

DOXYLAMINE SUCCINATE was reported 6083 times

DOXYLAMINE SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA 4 0.0784
1 RECTOURETHRAL FISTULA 3 0.0526
2 HUMAN CHORIONIC GONADOTROPIN DECREASED 5 0.0450
3 ALCOHOL TEST POSITIVE 2 0.0426
4 THERAPEUTIC PRODUCT EFFECT PROLONGED 15 0.0331
5 COLON GANGRENE 3 0.0323
6 OLFACTORY NERVE DISORDER 2 0.0299
7 FOREIGN BODY INGESTION 3 0.0268
8 HEMIVERTEBRA 3 0.0178
9 EXTENSOR PLANTAR RESPONSE 16 0.0174
10 CREATININE URINE ABNORMAL 2 0.0161
11 AMNIORRHOEA 3 0.0158
12 FAILED INDUCTION OF LABOUR 3 0.0155
13 HANGOVER 53 0.0151
14 LABOUR INDUCTION 2 0.0147
15 CALCIUM IONISED INCREASED 2 0.0145
16 FOETAL HEART RATE ABNORMAL 13 0.0140
17 RENAL NECROSIS 3 0.0138
18 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 2 0.0136
19 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 3 0.0129
20 MYOCARDIAL NECROSIS 3 0.0129
21 EXPOSURE TO TOXIC AGENT 35 0.0109
22 VICTIM OF CHEMICAL SUBMISSION 7 0.0104
23 HYPNAGOGIC HALLUCINATION 3 0.0098
24 THERAPEUTIC PRODUCT EFFECT VARIABLE 38 0.0098
25 THERAPEUTIC PRODUCT EFFECT DELAYED 42 0.0092
26 DRUG EFFECT PROLONGED 5 0.0091
27 NONREASSURING FOETAL HEART RATE PATTERN 2 0.0090
28 FIBROADENOMA OF BREAST 4 0.0089
29 CONTINUOUS POSITIVE AIRWAY PRESSURE 2 0.0087
30 PARANASAL SINUS HYPOSECRETION 2 0.0080
31 CHEMICAL SUBMISSION 2 0.0079
32 CHILD ABUSE 2 0.0077
33 PYROGLUTAMIC ACIDOSIS 3 0.0076
34 CONGENITAL EYE DISORDER 2 0.0075
35 MORNING SICKNESS 4 0.0073
36 HYPERTELORISM OF ORBIT 3 0.0072
37 ANENCEPHALY 4 0.0071
38 DERMATOPHYTOSIS 2 0.0070
39 CARBON MONOXIDE POISONING 3 0.0070
40 SHORTENED CERVIX 2 0.0068
41 POOR DENTAL CONDITION 2 0.0068
42 SUDDEN INFANT DEATH SYNDROME 3 0.0061
43 NEONATAL ASPIRATION 2 0.0061
44 ACQUIRED OESOPHAGEAL WEB 2 0.0059
45 UTERINE CONTRACTIONS DURING PREGNANCY 6 0.0058
46 BREAST HYPERPLASIA 2 0.0057
47 ANAL ATRESIA 3 0.0056
48 POSTMORTEM BLOOD DRUG LEVEL INCREASED 2 0.0054
49 HYPEREMESIS GRAVIDARUM 2 0.0052
50 HEARING DISABILITY 2 0.0051
51 CLONUS 14 0.0051
52 LYMPHOCYTIC LEUKAEMIA 2 0.0049
53 TWIN PREGNANCY 4 0.0048
54 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 32 0.0047
55 SKULL MALFORMATION 3 0.0047
56 GESTATIONAL HYPERTENSION 6 0.0046
57 NITRITE URINE PRESENT 2 0.0046
58 PREMATURE SEPARATION OF PLACENTA 7 0.0045
59 DRUG EFFECT VARIABLE 5 0.0044
60 SEDATION COMPLICATION 11 0.0043
61 HYPERREFLEXIA 15 0.0043
62 PRETERM PREMATURE RUPTURE OF MEMBRANES 5 0.0042
63 AMNIOTIC CAVITY INFECTION 3 0.0041
64 MICROALBUMINURIA 3 0.0040
65 REDUCED FACIAL EXPRESSION 4 0.0039
66 POISONING DELIBERATE 36 0.0038
67 MUSCLE CONTRACTIONS INVOLUNTARY 13 0.0037
68 CRYSTAL URINE PRESENT 2 0.0036
69 CLEFT LIP AND PALATE 4 0.0036
70 PROTHROMBIN TIME SHORTENED 5 0.0036
71 HEPATITIS A 3 0.0035
72 INDUCED LABOUR 2 0.0034
73 HYPERTONIA 19 0.0033
74 INTESTINAL INFARCTION 3 0.0033
75 OESOPHAGEAL ATRESIA 2 0.0032
76 GASTROINTESTINAL EROSION 2 0.0031
77 ANOXIC ENCEPHALOPATHY 2 0.0031
78 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
79 DISTURBANCE IN SOCIAL BEHAVIOUR 7 0.0030
80 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
81 POLYHYDRAMNIOS 3 0.0029
82 UNDERDOSE 210 0.0029
83 OCULOGYRIC CRISIS 6 0.0028
84 SLEEP PARALYSIS 4 0.0027
85 SERRATIA INFECTION 2 0.0027
86 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 78 0.0027
87 ALCOHOL POISONING 7 0.0026
88 QRS AXIS ABNORMAL 2 0.0026
89 DRUG TOLERANCE INCREASED 2 0.0026
90 BREAST FEEDING 2 0.0026
91 PLACENTA PRAEVIA 2 0.0025
92 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
93 BREECH PRESENTATION 3 0.0024
94 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
95 GAZE PALSY 4 0.0023
96 INCORRECT PRODUCT ADMINISTRATION DURATION 50 0.0023
97 SOMNOLENCE 454 0.0023
98 SELECTIVE EATING DISORDER 2 0.0022
99 SUBSTANCE USE DISORDER 7 0.0022
100 CERUMEN IMPACTION 2 0.0022
101 POOR QUALITY SLEEP 47 0.0022
102 THERAPEUTIC PRODUCT EFFECT DECREASED 97 0.0022
103 SCROTAL SWELLING 2 0.0021
104 MATERNAL EXPOSURE DURING PREGNANCY 190 0.0021
105 PLACENTAL DISORDER 2 0.0021
106 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
107 PROSTATE INFECTION 2 0.0021
108 RED BLOOD CELLS URINE POSITIVE 2 0.0021
109 POISONING 26 0.0021
110 BRUXISM 11 0.0020
111 AUTONOMIC NEUROPATHY 2 0.0020
112 LIVE BIRTH 16 0.0019
113 NIGHTMARE 66 0.0019
114 METABOLIC ALKALOSIS 3 0.0019
115 MYDRIASIS 24 0.0019
116 RESTLESS LEGS SYNDROME 34 0.0019
117 INJECTION RELATED REACTION 3 0.0018
118 SMALL FOR DATES BABY 9 0.0018
119 DEMENTIA WITH LEWY BODIES 2 0.0018
120 HALO VISION 2 0.0018
121 FOOD AVERSION 3 0.0018
122 DRUG EFFECT DELAYED 8 0.0018
123 EXPOSURE DURING PREGNANCY 109 0.0018
124 VOMITING PROJECTILE 5 0.0017
125 NEPHROGENIC ANAEMIA 8 0.0017
126 PARTIAL SEIZURES 9 0.0017
127 BLOOD LACTIC ACID INCREASED 9 0.0017
128 RETINAL VASCULITIS 2 0.0017
129 DRUG USE DISORDER 14 0.0017
130 TONGUE DISORDER 12 0.0017
131 HYPERPARATHYROIDISM SECONDARY 4 0.0016
132 JAUNDICE NEONATAL 3 0.0016
133 PANCREATIC CYST 3 0.0016
134 ABNORMAL DREAMS 43 0.0016
135 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
136 PSYCHOMOTOR SKILLS IMPAIRED 4 0.0015
137 BRADYPNOEA 4 0.0015
138 TRIGGER FINGER 6 0.0015
139 CARBON DIOXIDE INCREASED 2 0.0015
140 DRUG SCREEN FALSE POSITIVE 4 0.0014
141 HYPOSPADIAS 3 0.0014
142 MICTURITION DISORDER 5 0.0014
143 PREMATURE LABOUR 8 0.0014
144 CATAPLEXY 2 0.0014
145 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
146 SEBORRHOEIC KERATOSIS 2 0.0014
147 MIOSIS 11 0.0014
148 ACUTE ABDOMEN 2 0.0014
149 TOXICITY TO VARIOUS AGENTS 229 0.0014
150 PRODUCT ADMINISTRATION ERROR 27 0.0013
151 MIXED LIVER INJURY 4 0.0013
152 DRUG TOXICITY 18 0.0013
153 FACE INJURY 5 0.0013
154 ACCIDENTAL OVERDOSE 47 0.0013
155 COMA 61 0.0013
156 SLUGGISHNESS 13 0.0013
157 PROSTATOMEGALY 5 0.0013
158 OSTEOSCLEROSIS 2 0.0013
159 PRE-ECLAMPSIA 6 0.0013
160 BLADDER PAIN 4 0.0013
161 GASTROINTESTINAL OBSTRUCTION 3 0.0012
162 AORTIC VALVE DISEASE 2 0.0012
163 BACTERIAL SEPSIS 4 0.0012
164 PENIS DISORDER 3 0.0012
165 EDUCATIONAL PROBLEM 2 0.0012
166 SEROTONIN SYNDROME 23 0.0012
167 ENERGY INCREASED 7 0.0012
168 SLEEP TALKING 2 0.0012
169 MIDDLE INSOMNIA 22 0.0012
170 MATERNAL DRUGS AFFECTING FOETUS 9 0.0012
171 BLOOD PH DECREASED 2 0.0012
172 TACHYPHRENIA 4 0.0012
173 ALOPECIA AREATA 2 0.0011
174 MUSCLE SPASTICITY 14 0.0011
175 NEONATAL RESPIRATORY DISTRESS SYNDROME 4 0.0011
176 NYSTAGMUS 6 0.0011
177 NASAL OEDEMA 2 0.0011
178 SUBDURAL HAEMORRHAGE 3 0.0011
179 RED BLOOD CELL COUNT INCREASED 3 0.0011
180 FEELING DRUNK 8 0.0011
181 ACCIDENTAL DEATH 2 0.0011
182 THERAPEUTIC RESPONSE DELAYED 3 0.0011
183 HYPERTENSIVE HEART DISEASE 2 0.0011
184 DRUG ABUSE 89 0.0011
185 STENOSIS 2 0.0011
186 SINUS TACHYCARDIA 15 0.0011
187 VENTRICULAR SEPTAL DEFECT 6 0.0010
188 INTENTIONAL OVERDOSE 67 0.0010
189 HYPOREFLEXIA 2 0.0010
190 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
191 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 73 0.0010
192 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
193 PREMATURE DELIVERY 16 0.0010
194 EXPOSURE VIA BREAST MILK 4 0.0010
195 EYELID PAIN 2 0.0010
196 COMPLETED SUICIDE 82 0.0010
197 HYPERSOMNIA 28 0.0010
198 FOETAL DEATH 5 0.0010
199 EYE CONTUSION 2 0.0009
200 SLEEP DEFICIT 2 0.0009
201 APPLICATION SITE SCAB 2 0.0009
202 HYPOVENTILATION 3 0.0009
203 SOMNAMBULISM 6 0.0009
204 ASPIRATION 10 0.0009
205 CEREBELLAR SYNDROME 2 0.0009
206 MIDDLE EAR EFFUSION 2 0.0009
207 FAECES PALE 2 0.0009
208 RHINITIS ALLERGIC 4 0.0009
209 BACTERIAL TEST POSITIVE 2 0.0009
210 ILEUS PARALYTIC 4 0.0009
211 WRONG PRODUCT ADMINISTERED 6 0.0009
212 HYPOPNOEA 3 0.0009
213 HYPERTRANSAMINASAEMIA 6 0.0009
214 CAROTID ARTERY STENOSIS 3 0.0009
215 ARTERIOSCLEROSIS 8 0.0008
216 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
217 PSYCHOMOTOR HYPERACTIVITY 14 0.0008
218 HAEMORRHAGIC DIATHESIS 3 0.0008
219 GESTATIONAL DIABETES 4 0.0008
220 RHABDOMYOLYSIS 35 0.0008
221 LACUNAR INFARCTION 2 0.0008
222 UTERINE LEIOMYOMA 6 0.0008
223 INFREQUENT BOWEL MOVEMENTS 2 0.0008
224 VEIN DISORDER 4 0.0008
225 NASAL DRYNESS 5 0.0008
226 HEPATIC NECROSIS 3 0.0008
227 SNORING 3 0.0008
228 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
229 CAESAREAN SECTION 9 0.0008
230 ACTINIC KERATOSIS 2 0.0008
231 HERPES SIMPLEX 5 0.0008
232 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
233 RESPIRATORY ACIDOSIS 3 0.0008
234 DRUG INEFFECTIVE 1004 0.0008
235 EXPIRED PRODUCT ADMINISTERED 25 0.0008
236 AREFLEXIA 2 0.0007
237 SUBSTANCE ABUSE 6 0.0007
238 NORMAL NEWBORN 4 0.0007
239 SKIN WRINKLING 2 0.0007
240 FEELING JITTERY 14 0.0007
241 POLYURIA 6 0.0007
242 BLOOD PHOSPHORUS INCREASED 2 0.0007
243 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
244 ENDOTRACHEAL INTUBATION 2 0.0007
245 END STAGE RENAL DISEASE 13 0.0007
246 SLEEP TERROR 3 0.0007
247 MUSCLE FATIGUE 3 0.0007
248 OESOPHAGEAL STENOSIS 2 0.0007
249 BRAIN FOG 11 0.0007
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
251 PREMATURE BABY 21 0.0007
252 SPEECH DISORDER DEVELOPMENTAL 2 0.0007
253 HORDEOLUM 3 0.0007
254 INSOMNIA 182 0.0007
255 INCORRECT DOSE ADMINISTERED 153 0.0007
256 URINARY TRACT DISORDER 3 0.0007
257 MYELOFIBROSIS 2 0.0007
258 REBOUND ACID HYPERSECRETION 2 0.0007
259 URINE ABNORMALITY 3 0.0007
260 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
261 ACUTE HEPATIC FAILURE 9 0.0007
262 FOETAL GROWTH RESTRICTION 4 0.0007
263 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
264 DRUG ABUSER 4 0.0007
265 DIASTOLIC DYSFUNCTION 2 0.0006
266 CARDIO-RESPIRATORY ARREST 27 0.0006
267 OLIGURIA 4 0.0006
268 FLANK PAIN 6 0.0006
269 FOREIGN BODY IN THROAT 2 0.0006
270 INFUSION SITE PRURITUS 2 0.0006
271 DRUG SCREEN POSITIVE 5 0.0006
272 FOETAL EXPOSURE DURING PREGNANCY 51 0.0006
273 ABORTION SPONTANEOUS 25 0.0006
274 STUPOR 2 0.0006
275 LOOSE TOOTH 2 0.0006
276 RESPIRATORY ARREST 17 0.0006
277 HORMONE LEVEL ABNORMAL 3 0.0006
278 INCORRECT DOSAGE ADMINISTERED 3 0.0006
279 ASPHYXIA 5 0.0006
280 SUSPECTED COVID-19 2 0.0006
281 PRODUCT FORMULATION ISSUE 4 0.0006
282 MULTIPLE DRUG OVERDOSE 3 0.0006
283 SKIN INJURY 2 0.0006
284 PROTEIN URINE PRESENT 3 0.0006
285 OLIGOHYDRAMNIOS 2 0.0006
286 FEELING ABNORMAL 143 0.0006
287 DRUG TOLERANCE 3 0.0006
288 CHRONIC KIDNEY DISEASE 45 0.0006
289 AKATHISIA 8 0.0006
290 ACCIDENT 7 0.0006
291 PERIPHERAL VASCULAR DISORDER 3 0.0006
292 BLOOD CREATININE ABNORMAL 2 0.0006
293 SCHIZOPHRENIA 7 0.0006
294 OVERDOSE 123 0.0006
295 SPINAL OSTEOARTHRITIS 5 0.0006
296 DYSTONIA 11 0.0006
297 HALLUCINATION, AUDITORY 9 0.0006
298 SUICIDE ATTEMPT 34 0.0006
299 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
300 FAECES DISCOLOURED 12 0.0006
301 INTENTIONAL PRODUCT MISUSE 48 0.0005
302 JAW DISORDER 3 0.0005
303 FOOD INTOLERANCE 2 0.0005
304 ASTHENOPIA 3 0.0005
305 HYPERKERATOSIS 3 0.0005
306 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
307 PARANASAL SINUS DISCOMFORT 2 0.0005
308 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
309 ACIDOSIS 4 0.0005
310 PNEUMONIA ASPIRATION 13 0.0005
311 EXTRA DOSE ADMINISTERED 21 0.0005
312 SENSATION OF HEAVINESS 2 0.0005
313 PELVIC FRACTURE 4 0.0005
314 DECREASED INTEREST 3 0.0005
315 OESOPHAGEAL CANDIDIASIS 2 0.0005
316 CEREBRAL ATROPHY 2 0.0005
317 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
318 FUNGAL SKIN INFECTION 2 0.0005
319 SEASONAL ALLERGY 7 0.0005
320 BODY TEMPERATURE INCREASED 10 0.0005
321 INITIAL INSOMNIA 5 0.0005
322 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
323 SPINAL COMPRESSION FRACTURE 4 0.0005
324 DRUG LEVEL INCREASED 8 0.0005
325 ATRIAL SEPTAL DEFECT 4 0.0005
326 HYPERPYREXIA 2 0.0005
327 BUNDLE BRANCH BLOCK LEFT 2 0.0005
328 AORTIC VALVE INCOMPETENCE 2 0.0005
329 INTERVERTEBRAL DISC DISORDER 2 0.0005
330 HEPATIC PAIN 2 0.0005
331 RESTLESSNESS 17 0.0005
332 ACUTE KIDNEY INJURY 71 0.0005
333 INCOHERENT 3 0.0005
334 HYPERPROLACTINAEMIA 3 0.0005
335 APPLICATION SITE VESICLES 3 0.0005
336 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
337 DRY MOUTH 37 0.0005
338 DISORIENTATION 18 0.0005
339 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
340 PHYSICAL DISABILITY 2 0.0005
341 IRRITABILITY 27 0.0004
342 PRODUCT LABEL ISSUE 3 0.0004
343 TACHYPNOEA 6 0.0004
344 IMPAIRED DRIVING ABILITY 5 0.0004
345 EYE MOVEMENT DISORDER 3 0.0004
346 RENAL INJURY 13 0.0004
347 EAR DISORDER 2 0.0004
348 RESPIRATION ABNORMAL 3 0.0004
349 ENCEPHALITIS 3 0.0004
350 PERSONALITY CHANGE 4 0.0004
351 HALLUCINATION, VISUAL 9 0.0004
352 SKIN ABRASION 2 0.0004
353 ENDOMETRIOSIS 2 0.0004
354 GASTRITIS 11 0.0004
355 PANIC REACTION 3 0.0004
356 FAECES SOFT 3 0.0004
357 DIZZINESS POSTURAL 4 0.0004
358 PANIC ATTACK 15 0.0004
359 HALLUCINATION 31 0.0004
360 ORAL HERPES 8 0.0004
361 AGITATION 30 0.0004
362 RESPIRATORY DEPRESSION 5 0.0004
363 COELIAC DISEASE 4 0.0004
364 VITREOUS FLOATERS 4 0.0004
365 PARANOIA 7 0.0004
366 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
367 PREGNANCY 8 0.0004
368 BRAIN OEDEMA 5 0.0004
369 MOTOR DYSFUNCTION 4 0.0004
370 HEPATIC CYTOLYSIS 5 0.0004
371 INCREASED UPPER AIRWAY SECRETION 2 0.0004
372 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
373 CONCUSSION 3 0.0004
374 MALABSORPTION 2 0.0004
375 TORSADE DE POINTES 3 0.0004
376 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
377 AFFECTIVE DISORDER 3 0.0004
378 PULMONARY CONGESTION 5 0.0004
379 JOINT DISLOCATION 4 0.0004
380 LOW BIRTH WEIGHT BABY 3 0.0004
381 EYE HAEMORRHAGE 5 0.0004
382 BODY HEIGHT DECREASED 4 0.0004
383 SENSORY DISTURBANCE 6 0.0004
384 HAIR TEXTURE ABNORMAL 5 0.0004
385 DRUG EFFECT DECREASED 20 0.0004
386 BEHAVIOUR DISORDER 2 0.0004
387 AMNESIA 24 0.0004
388 PALPITATIONS 43 0.0004
389 GINGIVAL BLEEDING 5 0.0004
390 ACUTE RESPIRATORY FAILURE 7 0.0004
391 AUTISM SPECTRUM DISORDER 2 0.0004
392 ERUCTATION 7 0.0004
393 TACHYCARDIA 32 0.0004
394 HUNGER 5 0.0004
395 SNEEZING 8 0.0004
396 SENSATION OF FOREIGN BODY 3 0.0004
397 FACE OEDEMA 6 0.0004
398 CHROMATURIA 8 0.0004
399 SLEEP DISORDER 25 0.0004
400 NEUROLOGICAL SYMPTOM 2 0.0003
401 TREMOR 58 0.0003
402 TINNITUS 16 0.0003
403 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
404 MUSCLE STRAIN 3 0.0003
405 CARDIAC MURMUR 3 0.0003
406 PRODUCT LABEL CONFUSION 2 0.0003
407 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
408 HYPERKALAEMIA 12 0.0003
409 HYPOVOLAEMIA 2 0.0003
410 HEAD DISCOMFORT 6 0.0003
411 DISTURBANCE IN ATTENTION 18 0.0003
412 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
413 DEVELOPMENTAL DELAY 3 0.0003
414 PLATELET COUNT ABNORMAL 2 0.0003
415 NOCTURIA 4 0.0003
416 INGUINAL HERNIA 2 0.0003
417 RETCHING 7 0.0003
418 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
419 NERVOUSNESS 17 0.0003
420 MIGRAINE 31 0.0003
421 EMOTIONAL DISORDER 10 0.0003
422 PRODUCT DISTRIBUTION ISSUE 3 0.0003
423 HAIR COLOUR CHANGES 4 0.0003
424 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
425 PRE-EXISTING CONDITION IMPROVED 2 0.0003
426 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
427 ABORTION INDUCED 3 0.0003
428 INFUSION SITE SWELLING 2 0.0003
429 TRANSAMINASES INCREASED 7 0.0003
430 EYE INFLAMMATION 3 0.0003
431 SCREAMING 2 0.0003
432 HEART RATE INCREASED 31 0.0003
433 ENTERITIS 2 0.0003
434 SINUS BRADYCARDIA 3 0.0003
435 UNRESPONSIVE TO STIMULI 8 0.0003
436 CARDIAC FLUTTER 2 0.0003
437 VITAMIN D DEFICIENCY 3 0.0003
438 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
439 SEDATION 8 0.0003
440 HOSPICE CARE 3 0.0003
441 TOOTH INFECTION 4 0.0003
442 SINUS DISORDER 6 0.0003
443 BLADDER DISORDER 3 0.0003
444 CARDIAC FAILURE ACUTE 2 0.0003
445 URINARY RETENTION 10 0.0003
446 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
447 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
448 FATIGUE 232 0.0003
449 HYPOTHERMIA 3 0.0003
450 ANGER 10 0.0003
451 LETHARGY 17 0.0003
452 PRODUCT PRESCRIBING ERROR 7 0.0003
453 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
454 JOINT EFFUSION 2 0.0003
455 HAIR GROWTH ABNORMAL 2 0.0003
456 MENTAL IMPAIRMENT 7 0.0003
457 EYE DISCHARGE 3 0.0003
458 TENDERNESS 3 0.0003
459 PETECHIAE 3 0.0003
460 FORMICATION 2 0.0003
461 HYPOMAGNESAEMIA 4 0.0003
462 ORTHOSTATIC HYPOTENSION 5 0.0003
463 INTENTIONAL DRUG MISUSE 6 0.0003
464 DRUG-INDUCED LIVER INJURY 9 0.0003
465 EXTRASYSTOLES 2 0.0003
466 PRODUCT ODOUR ABNORMAL 3 0.0003
467 DRUG INTERACTION 45 0.0003
468 RENAL PAIN 3 0.0003
469 HYPOKALAEMIA 13 0.0003
470 ANXIETY 80 0.0003
471 JOINT INJURY 6 0.0003
472 DRY EYE 14 0.0003
473 HEREDITARY ANGIOEDEMA 3 0.0003
474 HYPERHIDROSIS 36 0.0003
475 RENAL FAILURE 37 0.0003
476 IMPAIRED QUALITY OF LIFE 4 0.0003
477 DIZZINESS 138 0.0003
478 HYPERTHYROIDISM 4 0.0003
479 LEUKOCYTOSIS 5 0.0003
480 TOOTHACHE 5 0.0003
481 BACK INJURY 3 0.0003
482 EYE DISORDER 9 0.0003
483 ORAL DISORDER 2 0.0003
484 GASTROINTESTINAL PAIN 3 0.0003
485 INJECTION SITE NODULE 3 0.0003
486 DRUG WITHDRAWAL SYNDROME NEONATAL 4 0.0003
487 MEDICATION ERROR 15 0.0003
488 VISION BLURRED 37 0.0003
489 RESPIRATORY TRACT INFECTION 7 0.0003
490 BACTERIAL INFECTION 5 0.0003
491 SKIN INFECTION 3 0.0003
492 HYPOAESTHESIA ORAL 4 0.0003
493 PAROSMIA 2 0.0003
494 MITRAL VALVE INCOMPETENCE 3 0.0003
495 MYALGIA 45 0.0003
496 BLOOD URINE PRESENT 5 0.0003
497 DERMATITIS CONTACT 3 0.0003
498 MICTURITION URGENCY 3 0.0003
499 GLAUCOMA 5 0.0003
500 FOOD ALLERGY 2 0.0003
501 MADAROSIS 3 0.0003
502 MUSCULOSKELETAL CHEST PAIN 4 0.0003
503 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
504 NICOTINE DEPENDENCE 2 0.0003
505 MOOD ALTERED 7 0.0003
506 CHOKING 5 0.0003
507 DYSGEUSIA 19 0.0003
508 MULTIPLE ALLERGIES 2 0.0003
509 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
510 ANAPHYLACTIC REACTION 14 0.0003
511 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
512 BLOOD ALBUMIN DECREASED 2 0.0003
513 CHOLECYSTITIS 3 0.0003
514 SCIATICA 4 0.0003
515 MYASTHENIA GRAVIS 2 0.0002
516 MUSCLE DISORDER 2 0.0002
517 DYSKINESIA 10 0.0002
518 POST PROCEDURAL INFECTION 2 0.0002
519 THERAPY NON-RESPONDER 11 0.0002
520 INJECTION SITE MASS 9 0.0002
521 CONSTIPATION 53 0.0002
522 HYPERCALCAEMIA 3 0.0002
523 HAIR DISORDER 2 0.0002
524 CARDIAC ARREST 20 0.0002
525 PHARYNGITIS 3 0.0002
526 MENSTRUAL DISORDER 2 0.0002
527 CONFUSIONAL STATE 39 0.0002
528 POLLAKIURIA 10 0.0002
529 DYSSTASIA 7 0.0002
530 BLOOD UREA INCREASED 4 0.0002
531 DERMATITIS ALLERGIC 3 0.0002
532 UNEVALUABLE EVENT 18 0.0002
533 PNEUMONIA 77 0.0002
534 SKIN PLAQUE 2 0.0002
535 CANDIDA INFECTION 4 0.0002
536 MUSCLE ATROPHY 3 0.0002
537 DRUG DEPENDENCE 38 0.0002
538 IMPAIRED WORK ABILITY 5 0.0002
539 PRODUCT CONTAINER ISSUE 2 0.0002
540 BLOOD POTASSIUM DECREASED 7 0.0002
541 ANOREXIA 3 0.0002
542 CARDIAC OPERATION 2 0.0002
543 MUSCULOSKELETAL DISCOMFORT 4 0.0002
544 RHINORRHOEA 15 0.0002
545 HIATUS HERNIA 3 0.0002
546 PRURITUS GENERALISED 5 0.0002
547 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
548 EYE PAIN 13 0.0002
549 ABDOMINAL DISTENSION 24 0.0002
550 NODULE 3 0.0002
551 VERTIGO 14 0.0002
552 BRONCHITIS 17 0.0002
553 HEART RATE DECREASED 8 0.0002
554 IMMUNE SYSTEM DISORDER 3 0.0002
555 PRODUCT COMMUNICATION ISSUE 2 0.0002
556 ADVERSE REACTION 3 0.0002
557 ORAL PAIN 5 0.0002
558 GASTROINTESTINAL INFECTION 2 0.0002
559 GOUT 4 0.0002
560 PRODUCT TASTE ABNORMAL 3 0.0002
561 GASTROENTERITIS VIRAL 4 0.0002
562 OROPHARYNGEAL DISCOMFORT 2 0.0002
563 HEART RATE IRREGULAR 5 0.0002
564 OPTIC NEURITIS 2 0.0002
565 LOSS OF CONSCIOUSNESS 28 0.0002
566 INCREASED TENDENCY TO BRUISE 2 0.0002
567 MUSCLE TWITCHING 5 0.0002
568 GRAND MAL CONVULSION 2 0.0002
569 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
570 MENTAL STATUS CHANGES 6 0.0002
571 ORAL DISCOMFORT 3 0.0002
572 CONJUNCTIVITIS 4 0.0002
573 APHONIA 3 0.0002
574 THINKING ABNORMAL 4 0.0002
575 NEPHROPATHY 2 0.0002
576 DYSPEPSIA 21 0.0002
577 BLINDNESS UNILATERAL 3 0.0002
578 HEPATOCELLULAR INJURY 3 0.0002
579 INTENTIONAL DOSE OMISSION 6 0.0002
580 VIRAL INFECTION 7 0.0002
581 BRONCHOSPASM 3 0.0002
582 PARAESTHESIA 33 0.0002
583 SLEEP APNOEA SYNDROME 4 0.0002
584 PRODUCTIVE COUGH 10 0.0002
585 INCREASED APPETITE 4 0.0002
586 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
587 DEPRESSED MOOD 11 0.0002
588 FALL 69 0.0002
589 HERNIA 4 0.0002
590 PRESCRIBED OVERDOSE 4 0.0002
591 HYPOKINESIA 3 0.0002
592 HEADACHE 129 0.0002
593 ABDOMINAL DISCOMFORT 34 0.0002
594 ABNORMAL BEHAVIOUR 8 0.0002
595 PULMONARY MASS 3 0.0002
596 CONDITION AGGRAVATED 61 0.0002
597 HEPATIC FAILURE 6 0.0002
598 FULL BLOOD COUNT DECREASED 4 0.0002
599 DRY THROAT 2 0.0002
600 MUSCLE SPASMS 36 0.0002
601 INJECTION SITE RASH 6 0.0002
602 DRUG ADMINISTRATION ERROR 6 0.0002
603 EUPHORIC MOOD 2 0.0002
604 SINUSITIS 20 0.0002
605 EAR DISCOMFORT 2 0.0002
606 ERECTILE DYSFUNCTION 5 0.0002
607 INJECTION SITE WARMTH 4 0.0002
608 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
609 DRUG EFFECT INCOMPLETE 7 0.0002
610 CYANOSIS 3 0.0002
611 FOLLICULITIS 2 0.0002
612 WITHDRAWAL SYNDROME 8 0.0002
613 SEIZURE 22 0.0002
614 PRODUCT USE COMPLAINT 3 0.0002
615 INJECTION SITE DISCOMFORT 2 0.0002
616 OCULAR HYPERAEMIA 9 0.0002
617 SCRATCH 2 0.0002
618 FULL BLOOD COUNT ABNORMAL 2 0.0002
619 ASTHENIA 71 0.0002
620 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
621 HIP FRACTURE 6 0.0002
622 NIGHT SWEATS 6 0.0002
623 FEAR 5 0.0002
624 HYPOGLYCAEMIA 9 0.0002
625 DECREASED ACTIVITY 2 0.0002
626 MUSCLE TIGHTNESS 3 0.0002
627 BALANCE DISORDER 16 0.0002
628 FREQUENT BOWEL MOVEMENTS 5 0.0002
629 PHARYNGITIS STREPTOCOCCAL 2 0.0002
630 MUSCULAR WEAKNESS 21 0.0002
631 MENTAL DISORDER 8 0.0002
632 PULMONARY THROMBOSIS 2 0.0002
633 WEIGHT INCREASED 41 0.0002
634 DEPENDENCE 10 0.0002
635 MEMORY IMPAIRMENT 25 0.0002
636 PHOTOSENSITIVITY REACTION 3 0.0002
637 DIVERTICULITIS 5 0.0002
638 HYPOAESTHESIA 27 0.0002
639 FUNGAL INFECTION 6 0.0002
640 SKIN DISORDER 6 0.0002
641 NERVE INJURY 2 0.0002
642 AGGRESSION 9 0.0002
643 ABDOMINAL PAIN UPPER 37 0.0002
644 GAIT INABILITY 6 0.0002
645 PULMONARY OEDEMA 8 0.0002
646 RASH PAPULAR 4 0.0002
647 CHEST PAIN 33 0.0002
648 OCULAR DISCOMFORT 2 0.0002
649 HYPERSENSITIVITY 33 0.0002
650 HEMIPARESIS 3 0.0002
651 FLUID RETENTION 9 0.0002
652 BLOOD PRESSURE INCREASED 27 0.0002
653 CIRCULATORY COLLAPSE 3 0.0002
654 SCAB 2 0.0002
655 INTERNAL HAEMORRHAGE 2 0.0002
656 HYPOTENSION 35 0.0002
657 VOMITING 82 0.0002
658 INFLAMMATION 9 0.0002
659 SHOCK 4 0.0002
660 EPISTAXIS 13 0.0002
661 EYE IRRITATION 10 0.0002
662 METASTASES TO LUNG 2 0.0002
663 HOT FLUSH 13 0.0002
664 ELECTROLYTE IMBALANCE 2 0.0002
665 POST PROCEDURAL HAEMORRHAGE 2 0.0002
666 AMENORRHOEA 3 0.0002
667 BONE PAIN 10 0.0002
668 SPINAL PAIN 2 0.0002
669 HYPOXIA 6 0.0002
670 PRODUCT USE ISSUE 32 0.0002
671 COLD SWEAT 3 0.0002
672 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
673 LYMPHOCYTE COUNT DECREASED 3 0.0002
674 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
675 COVID-19 PNEUMONIA 2 0.0002
676 PSYCHOTIC DISORDER 5 0.0002
677 ATAXIA 2 0.0002
678 NASOPHARYNGITIS 31 0.0002
679 GALLBLADDER DISORDER 3 0.0002
680 BACK PAIN 39 0.0002
681 MACULAR DEGENERATION 2 0.0002
682 RENAL IMPAIRMENT 14 0.0002
683 BLOOD GLUCOSE DECREASED 8 0.0002
684 SKIN EXFOLIATION 14 0.0002
685 NO ADVERSE EVENT 30 0.0002
686 EMOTIONAL DISTRESS 20 0.0002
687 ILLNESS 17 0.0002
688 DEHYDRATION 22 0.0002
689 THERAPEUTIC RESPONSE DECREASED 10 0.0002
690 PRESYNCOPE 4 0.0002
691 NAUSEA 130 0.0002
692 INJECTION SITE PRURITUS 11 0.0002
693 DYSURIA 6 0.0002
694 LIVER INJURY 4 0.0002
695 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
696 SMALL INTESTINAL OBSTRUCTION 2 0.0002
697 SPINAL OPERATION 2 0.0002
698 OROPHARYNGEAL PAIN 15 0.0002
699 ABASIA 4 0.0002
700 HEPATIC STEATOSIS 3 0.0002
701 SECRETION DISCHARGE 2 0.0002
702 DYSARTHRIA 6 0.0002
703 FOOT FRACTURE 3 0.0002
704 ANGIOEDEMA 7 0.0002
705 NEUROPATHY PERIPHERAL 15 0.0002
706 MUSCULOSKELETAL DISORDER 3 0.0002
707 FLUSHING 16 0.0002
708 CYSTITIS 5 0.0002
709 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
710 METABOLIC ACIDOSIS 5 0.0002
711 CHEST DISCOMFORT 16 0.0002
712 CHOLESTASIS 3 0.0002
713 LOWER LIMB FRACTURE 3 0.0002
714 THROAT IRRITATION 7 0.0002
715 THERAPY CESSATION 8 0.0002
716 RASH GENERALISED 4 0.0002
717 INJECTION SITE INDURATION 2 0.0002
718 DEEP VEIN THROMBOSIS 10 0.0002
719 DEPRESSION 35 0.0002
720 PRODUCT DOSE OMISSION 10 0.0002
721 SPEECH DISORDER 8 0.0002
722 CHOLELITHIASIS 5 0.0002
723 INFLUENZA 17 0.0002
724 ANAEMIA 29 0.0002
725 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
726 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
727 BLOOD PRESSURE ABNORMAL 3 0.0002
728 DYSMENORRHOEA 2 0.0002
729 RESPIRATORY FAILURE 11 0.0002
730 UPPER LIMB FRACTURE 3 0.0002
731 BLOOD PRESSURE DECREASED 10 0.0002
732 ABDOMINAL PAIN 35 0.0002
733 PRESCRIBED UNDERDOSE 3 0.0002
734 EAR INFECTION 4 0.0002
735 BLOOD CHOLESTEROL INCREASED 7 0.0002
736 COGNITIVE DISORDER 7 0.0001
737 PAIN IN EXTREMITY 44 0.0001
738 MALIGNANT MELANOMA 2 0.0001
739 DIARRHOEA 96 0.0001
740 INTENTIONAL SELF-INJURY 3 0.0001
741 STOMATITIS 9 0.0001
742 SINUS CONGESTION 2 0.0001
743 THROAT TIGHTNESS 4 0.0001
744 DISEASE RECURRENCE 7 0.0001
745 WEIGHT DECREASED 41 0.0001
746 FEELING HOT 9 0.0001
747 IMPAIRED GASTRIC EMPTYING 2 0.0001
748 HEPATIC ENZYME INCREASED 10 0.0001
749 OSTEOPOROSIS 6 0.0001
750 RIB FRACTURE 3 0.0001
751 CORONARY ARTERY OCCLUSION 2 0.0001
752 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
753 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
754 DYSPNOEA 82 0.0001
755 ADVERSE DRUG REACTION 13 0.0001
756 FEELING COLD 4 0.0001
757 ROAD TRAFFIC ACCIDENT 6 0.0001
758 DEMENTIA 4 0.0001
759 MASS 2 0.0001
760 LUNG DISORDER 7 0.0001
761 MOUTH ULCERATION 3 0.0001
762 DEVICE OCCLUSION 2 0.0001
763 SKIN REACTION 2 0.0001
764 LYMPHADENOPATHY 5 0.0001
765 PAIN IN JAW 4 0.0001
766 RED BLOOD CELL COUNT DECREASED 4 0.0001
767 CONVULSION 8 0.0001
768 CARDIOGENIC SHOCK 2 0.0001
769 SKIN CANCER 3 0.0001
770 MOBILITY DECREASED 10 0.0001
771 MALAISE 61 0.0001
772 VAGINAL HAEMORRHAGE 6 0.0001
773 PRURITUS 53 0.0001
774 INJECTION SITE BRUISING 11 0.0001
775 CRYING 5 0.0001
776 HYPERGLYCAEMIA 5 0.0001
777 APATHY 2 0.0001
778 HYPERTENSION 29 0.0001
779 CARDIOMYOPATHY 2 0.0001
780 TOOTH DISORDER 3 0.0001
781 RASH MACULO-PAPULAR 3 0.0001
782 URINARY TRACT INFECTION 23 0.0001
783 EYE SWELLING 5 0.0001
784 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
785 RESPIRATORY DISORDER 4 0.0001
786 MUSCULOSKELETAL PAIN 7 0.0001
787 ATRIAL FIBRILLATION 13 0.0001
788 DECREASED APPETITE 31 0.0001
789 DYSPNOEA EXERTIONAL 5 0.0001
790 APHASIA 4 0.0001
791 LACRIMATION INCREASED 4 0.0001
792 PAIN 81 0.0001
793 INJECTION SITE REACTION 9 0.0001
794 INSURANCE ISSUE 2 0.0001
795 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
796 SYNCOPE 13 0.0001
797 LIMB DISCOMFORT 4 0.0001
798 RENAL DISORDER 6 0.0001
799 EJECTION FRACTION DECREASED 2 0.0001
800 SWELLING 12 0.0001
801 BASAL CELL CARCINOMA 2 0.0001
802 NERVOUS SYSTEM DISORDER 4 0.0001
803 OFF LABEL USE 111 0.0001
804 HEAD INJURY 4 0.0001
805 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
806 RASH ERYTHEMATOUS 6 0.0001
807 COVID-19 22 0.0001
808 HYPOTHYROIDISM 4 0.0001
809 BLOOD PRESSURE FLUCTUATION 3 0.0001
810 CONTUSION 12 0.0001
811 LOCALISED INFECTION 3 0.0001
812 LACTIC ACIDOSIS 4 0.0001
813 FLATULENCE 7 0.0001
814 NEURALGIA 3 0.0001
815 BLOOD POTASSIUM INCREASED 2 0.0001
816 BACK DISORDER 2 0.0001
817 SWELLING FACE 8 0.0001
818 INJECTION SITE URTICARIA 3 0.0001
819 PRODUCT SUBSTITUTION ISSUE 7 0.0001
820 MANIA 2 0.0001
821 OSTEONECROSIS OF JAW 3 0.0001
822 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
823 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
824 VISUAL ACUITY REDUCED 4 0.0001
825 ARTHRALGIA 50 0.0001
826 SUICIDAL IDEATION 11 0.0001
827 COAGULOPATHY 2 0.0001
828 CHILLS 14 0.0001
829 ADVERSE EVENT 11 0.0001
830 NASAL CONGESTION 7 0.0001
831 HAEMOGLOBIN DECREASED 12 0.0001
832 SCAR 2 0.0001
833 HAEMATURIA 4 0.0001
834 ERYTHEMA 24 0.0001
835 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
836 HYPOACUSIS 5 0.0001
837 DYSPHAGIA 11 0.0001
838 PYREXIA 40 0.0001
839 ILL-DEFINED DISORDER 7 0.0001
840 DEAFNESS 3 0.0001
841 LOCAL SWELLING 2 0.0001
842 INJURY 8 0.0001
843 BRADYCARDIA 6 0.0001
844 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
845 CARDIAC FAILURE 9 0.0001
846 MENSTRUATION IRREGULAR 3 0.0001
847 PAIN OF SKIN 3 0.0001
848 BLOOD BILIRUBIN INCREASED 3 0.0001
849 LIMB INJURY 3 0.0001
850 GAIT DISTURBANCE 21 0.0001
851 RESPIRATORY DISTRESS 3 0.0001
852 JOINT SWELLING 13 0.0001
853 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
854 BLOOD CREATININE INCREASED 7 0.0001
855 OEDEMA PERIPHERAL 13 0.0001
856 HYPONATRAEMIA 6 0.0001
857 HEPATIC CIRRHOSIS 2 0.0001
858 ARRHYTHMIA 5 0.0001
859 COLITIS 4 0.0001
860 GASTRIC ULCER 2 0.0001
861 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
862 PROTEINURIA 2 0.0001
863 VISUAL IMPAIRMENT 13 0.0001
864 DRY SKIN 14 0.0001
865 COUGH 29 0.0001
866 PLATELET COUNT DECREASED 11 0.0001
867 EAR PAIN 2 0.0001
868 MUSCULOSKELETAL STIFFNESS 9 0.0001
869 DYSPHONIA 6 0.0001
870 PLASMA CELL MYELOMA 4 0.0001
871 SKIN FISSURES 2 0.0001
872 MENORRHAGIA 2 0.0001
873 LABORATORY TEST ABNORMAL 3 0.0001
874 HAEMATOCRIT DECREASED 2 0.0001
875 CATARACT 6 0.0001
876 SPINAL FRACTURE 2 0.0001
877 PRODUCT PHYSICAL ISSUE 2 0.0001
878 PERIPHERAL SWELLING 15 0.0001
879 LUNG NEOPLASM MALIGNANT 4 0.0001
880 ALOPECIA 19 0.0001
881 PULMONARY HYPERTENSION 2 0.0001
882 HAEMORRHAGE 10 0.0001
883 KNEE ARTHROPLASTY 2 0.0001
884 PULMONARY EMBOLISM 9 0.0001
885 INJECTION SITE PAIN 29 0.0001
886 OSTEOARTHRITIS 4 0.0001
887 MOOD SWINGS 3 0.0001
888 RASH 41 0.0001
889 DRUG INTOLERANCE 9 0.0001
890 LIVER FUNCTION TEST INCREASED 2 0.0001
891 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
892 DRUG WITHDRAWAL SYNDROME 8 0.0001
893 STAPHYLOCOCCAL INFECTION 3 0.0001
894 INFUSION RELATED REACTION 6 0.0001
895 LIP SWELLING 3 0.0001
896 URTICARIA 15 0.0001
897 NECK PAIN 5 0.0001
898 GLOSSODYNIA 2 0.0001
899 PANCREATITIS ACUTE 2 0.0001
900 OXYGEN SATURATION DECREASED 5 0.0001
901 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
902 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
903 GASTRIC DISORDER 3 0.0001
904 SKIN DISCOLOURATION 4 0.0001
905 HERPES ZOSTER 5 0.0001
906 SURGERY 5 0.0001
907 INFLUENZA LIKE ILLNESS 7 0.0001
908 DISEASE PROGRESSION 10 0.0001
909 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
910 PSORIASIS 11 0.0001
911 PRODUCT ADHESION ISSUE 3 0.0001
912 MULTIPLE SCLEROSIS 4 0.0001
913 DIABETIC KETOACIDOSIS 2 0.0001
914 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
915 INFECTION 12 0.0001
916 DEATH 71 0.0001
917 FIBROMYALGIA 2 0.0001
918 DISCOMFORT 5 0.0001
919 ENCEPHALOPATHY 2 0.0001
920 INJECTION SITE ERYTHEMA 10 0.0001
921 AGEUSIA 2 0.0001
922 ASTHMA 9 0.0001
923 INTESTINAL OBSTRUCTION 3 0.0001
924 CARDIOVASCULAR DISORDER 2 0.0001
925 DIABETES MELLITUS 6 0.0001
926 HYPOPHAGIA 2 0.0001
927 GASTROINTESTINAL DISORDER 7 0.0001
928 DIPLOPIA 2 0.0001
929 APPLICATION SITE ERYTHEMA 2 0.0001
930 JOINT STIFFNESS 2 0.0001
931 ANHEDONIA 2 0.0001
932 THROMBOSIS 6 0.0001
933 JAUNDICE 2 0.0001
934 RASH PRURITIC 4 0.0001
935 PRODUCT QUALITY ISSUE 10 0.0001
936 BLINDNESS 3 0.0001
937 PALLOR 2 0.0001
938 PNEUMONITIS 2 0.0001
939 SKIN LESION 2 0.0001
940 SEPSIS 8 0.0001
941 HAEMOPTYSIS 2 0.0001
942 PANCYTOPENIA 4 0.0001
943 PRODUCT DOSE OMISSION ISSUE 21 0.0001
944 BURNING SENSATION 5 0.0001
945 BLISTER 4 0.0001
946 RENAL FAILURE ACUTE 3 0.0001
947 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
948 RECTAL HAEMORRHAGE 3 0.0001
949 ANGINA PECTORIS 2 0.0001
950 DEVICE DISLOCATION 3 0.0001
951 NEEDLE ISSUE 2 0.0001
952 ACUTE MYOCARDIAL INFARCTION 2 0.0001
953 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
954 CORONARY ARTERY DISEASE 2 0.0001
955 ACNE 5 0.0001
956 INJECTION SITE SWELLING 5 0.0001
957 GYNAECOMASTIA 2 0.0001
958 INJECTION SITE HAEMORRHAGE 5 0.0001
959 MOVEMENT DISORDER 2 0.0001
960 DRUG DOSE OMISSION 10 0.0001
961 BLOOD GLUCOSE INCREASED 11 0.0001
962 DELIRIUM 2 0.0001
963 DEVICE USE ERROR 2 0.0001
964 NEOPLASM PROGRESSION 2 0.0001
965 ECZEMA 3 0.0001
966 RASH MACULAR 2 0.0001
967 SKIN BURNING SENSATION 4 0.0001
968 DEVICE ISSUE 5 0.0001
969 CARDIAC DISORDER 5 0.0001
970 RHEUMATOID ARTHRITIS 6 0.0001
971 ARTHRITIS 4 0.0001
972 CARDIAC FAILURE CONGESTIVE 4 0.0000
973 DEVICE LEAKAGE 2 0.0000
974 FEBRILE NEUTROPENIA 3 0.0000
975 NEOPLASM MALIGNANT 3 0.0000
976 COLITIS ULCERATIVE 2 0.0000
977 NEPHROLITHIASIS 2 0.0000
978 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
979 THERAPY INTERRUPTED 3 0.0000
980 CEREBROVASCULAR ACCIDENT 7 0.0000
981 CELLULITIS 2 0.0000
982 HOSPITALISATION 6 0.0000
983 PANCREATITIS 2 0.0000
984 TREATMENT FAILURE 3 0.0000
985 ARTHROPATHY 2 0.0000
986 PLEURAL EFFUSION 2 0.0000
987 BREAST CANCER 3 0.0000
988 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
989 MYOCARDIAL INFARCTION 4 0.0000
990 PRODUCT STORAGE ERROR 2 0.0000